
Carlyle is expected to first buy around 50% stake from the promoters and their families at Rs 85-90 a share, or a 7-10% premium to the current market price, and then launch an open offer to the minority investors.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3bg1YEY
via
IFTTT
0 comments:
Post a Comment